Tim Moran is a MedTech executive with extensive experience leading global healthcare businesses and scaling both public and private companies. He has managed large commercial operations, including a >$1B P&L at Covidien and an $800M Americas business at ConvaTec.
He previously served as CEO of Motus GI, where he led FDA clearance, raised over $70M, and drove initial commercialization, and as CEO of Avertix Medical, where he guided the company from FDA approval through early commercialization and secured CMS reimbursement for its implantable heart attack detection system.
He is currently Chief Business Officer at Kestra Medical Technologies, focusing on strategy, market access, business development, and revenue growth.